Health & Fitness
Health and Fitness
Health and Fitness
Tue, July 27, 2010Mon, July 26, 2010Fri, July 23, 2010Thu, July 22, 2010Wed, July 21, 2010Tue, July 20, 2010Mon, July 19, 2010Sun, July 18, 2010Sat, July 17, 2010Fri, July 16, 2010Thu, July 15, 2010Wed, July 14, 2010Tue, July 13, 2010Mon, July 12, 2010Fri, July 9, 2010Thu, July 8, 2010Wed, July 7, 2010Tue, July 6, 2010Mon, July 5, 2010Fri, July 2, 2010Furiex Pharmaceuticals Announces Second Quarter 2010 Earnings Release and Conference Call
Published in Health and Fitness on Wednesday, July 14th 2010 at 13:35 GMT by Market Wire
MORRISVILLE, N.C.--([ BUSINESS WIRE ])--Furiex Pharmaceuticals, Inc. (Nasdaq: FURX) will release its second quarter 2010 financial results on Wednesday, August 11, 2010, after the market closes. The earnings news release will be available on the Furiex website at [ www.furiex.com ].
On Thursday, August 12, 2010, at 9 a.m. ET, Furiex will conduct a live conference call and audio webcast to discuss financial results and product portfolio. A Q&A session will follow. The conference call will be broadcast live over the Internet and will also be available using the following direct dial numbers:
| Participant dial-in: | +1 866 735 8913 (U.S./Canada) | ||
| +1 706 643 0961 (International) | |||
| Conference ID: | 87379426 |
All interested parties can access the webcast through the Presentations & Events link in the Investors section of the Furiex website at [ www.furiex.com ]. The webcast will be archived shortly after the call for on-demand replay.
About Furiex Pharmaceuticals
Furiex Pharmaceuticals is a drug development collaboration company using innovative clinical development design to accelerate and increase value of partnered drug programs by advancing them through the drug discovery and development process in a cost-efficient manner. Development programs are designed and driven by a core team with extensive drug development experience. The company collaborates with pharmaceutical and biotechnology companies and has a strong, diversified product portfolio and pipeline with multiple therapeutic candidates including late-stage assets and one product on the market. The companya™s mission is to develop innovative medicines faster and at less cost, reducing the expense of health care globally while providing life-improving therapies for patients. For more information, visit [ www.furiex.com ].
